Liposome doxorubicin is a commonly used anthracycline anti-tumor drug, and is one of the first-line drugs for ovarian cancer.
In North America, the highest incidence of sarcoma, ovarian cancer, breast and liver cancer, and several other cancers is the highest. North America has become a major market due to the existence of advanced healthcare facilities and a high level of patient awareness of the various available treatments.
The global Liposomal Doxorubicin market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Liposomal Doxorubicin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liposomal Doxorubicin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Liposomal Doxorubicin in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Liposomal Doxorubicin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Johnson & Johnson
Pfizer
Sun Pharmaceutical
Cadila Pharmaceuticals
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Intravenous Infusion
Injection
Segment by Application
Academic
Hospitals
Other
In North America, the highest incidence of sarcoma, ovarian cancer, breast and liver cancer, and several other cancers is the highest. North America has become a major market due to the existence of advanced healthcare facilities and a high level of patient awareness of the various available treatments.
The global Liposomal Doxorubicin market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Liposomal Doxorubicin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liposomal Doxorubicin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Liposomal Doxorubicin in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Liposomal Doxorubicin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Johnson & Johnson
Pfizer
Sun Pharmaceutical
Cadila Pharmaceuticals
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Intravenous Infusion
Injection
Segment by Application
Academic
Hospitals
Other
Table of Contents
Executive Summary
1 Industry Overview of Liposomal Doxorubicin
1.1 Definition of Liposomal Doxorubicin
1.2 Liposomal Doxorubicin Segment by Type
1.2.1 Global Liposomal Doxorubicin Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Intravenous Infusion
1.2.3 Injection
1.3 Liposomal Doxorubicin Segment by Applications
1.3.1 Global Liposomal Doxorubicin Consumption Comparison by Applications (2014-2025)
1.3.2 Academic
1.3.3 Hospitals
1.3.4 Other
1.4 Global Liposomal Doxorubicin Overall Market
1.4.1 Global Liposomal Doxorubicin Revenue (2014-2025)
1.4.2 Global Liposomal Doxorubicin Production (2014-2025)
1.4.3 North America Liposomal Doxorubicin Status and Prospect (2014-2025)
1.4.4 Europe Liposomal Doxorubicin Status and Prospect (2014-2025)
1.4.5 China Liposomal Doxorubicin Status and Prospect (2014-2025)
1.4.6 Japan Liposomal Doxorubicin Status and Prospect (2014-2025)
1.4.7 Southeast Asia Liposomal Doxorubicin Status and Prospect (2014-2025)
1.4.8 India Liposomal Doxorubicin Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Liposomal Doxorubicin
2.3 Manufacturing Process Analysis of Liposomal Doxorubicin
2.4 Industry Chain Structure of Liposomal Doxorubicin
3 Development and Manufacturing Plants Analysis of Liposomal Doxorubicin
3.1 Capacity and Commercial Production Date
3.2 Global Liposomal Doxorubicin Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Liposomal Doxorubicin
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Liposomal Doxorubicin Production and Capacity Analysis
4.2 Liposomal Doxorubicin Revenue Analysis
4.3 Liposomal Doxorubicin Price Analysis
4.4 Market Concentration Degree
5 Liposomal Doxorubicin Regional Market Analysis
5.1 Liposomal Doxorubicin Production by Regions
5.1.1 Global Liposomal Doxorubicin Production by Regions
5.1.2 Global Liposomal Doxorubicin Revenue by Regions
5.2 Liposomal Doxorubicin Consumption by Regions
5.3 North America Liposomal Doxorubicin Market Analysis
5.3.1 North America Liposomal Doxorubicin Production
5.3.2 North America Liposomal Doxorubicin Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Liposomal Doxorubicin Import and Export
5.4 Europe Liposomal Doxorubicin Market Analysis
5.4.1 Europe Liposomal Doxorubicin Production
5.4.2 Europe Liposomal Doxorubicin Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Liposomal Doxorubicin Import and Export
5.5 China Liposomal Doxorubicin Market Analysis
5.5.1 China Liposomal Doxorubicin Production
5.5.2 China Liposomal Doxorubicin Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Liposomal Doxorubicin Import and Export
5.6 Japan Liposomal Doxorubicin Market Analysis
5.6.1 Japan Liposomal Doxorubicin Production
5.6.2 Japan Liposomal Doxorubicin Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Liposomal Doxorubicin Import and Export
5.7 Southeast Asia Liposomal Doxorubicin Market Analysis
5.7.1 Southeast Asia Liposomal Doxorubicin Production
5.7.2 Southeast Asia Liposomal Doxorubicin Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Liposomal Doxorubicin Import and Export
5.8 India Liposomal Doxorubicin Market Analysis
5.8.1 India Liposomal Doxorubicin Production
5.8.2 India Liposomal Doxorubicin Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Liposomal Doxorubicin Import and Export
6 Liposomal Doxorubicin Segment Market Analysis (by Type)
6.1 Global Liposomal Doxorubicin Production by Type
6.2 Global Liposomal Doxorubicin Revenue by Type
6.3 Liposomal Doxorubicin Price by Type
7 Liposomal Doxorubicin Segment Market Analysis (by Application)
7.1 Global Liposomal Doxorubicin Consumption by Application
7.2 Global Liposomal Doxorubicin Consumption Market Share by Application (2014-2019)
8 Liposomal Doxorubicin Major Manufacturers Analysis
8.1 Johnson & Johnson
8.1.1 Johnson & Johnson Liposomal Doxorubicin Production Sites and Area Served
8.1.2 Johnson & Johnson Product Introduction, Application and Specification
8.1.3 Johnson & Johnson Liposomal Doxorubicin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer
8.2.1 Pfizer Liposomal Doxorubicin Production Sites and Area Served
8.2.2 Pfizer Product Introduction, Application and Specification
8.2.3 Pfizer Liposomal Doxorubicin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Sun Pharmaceutical
8.3.1 Sun Pharmaceutical Liposomal Doxorubicin Production Sites and Area Served
8.3.2 Sun Pharmaceutical Product Introduction, Application and Specification
8.3.3 Sun Pharmaceutical Liposomal Doxorubicin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Cadila Pharmaceuticals
8.4.1 Cadila Pharmaceuticals Liposomal Doxorubicin Production Sites and Area Served
8.4.2 Cadila Pharmaceuticals Product Introduction, Application and Specification
8.4.3 Cadila Pharmaceuticals Liposomal Doxorubicin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
9 Development Trend of Analysis of Liposomal Doxorubicin Market
9.1 Global Liposomal Doxorubicin Market Trend Analysis
9.1.1 Global Liposomal Doxorubicin Market Size (Volume and Value) Forecast 2019-2025
9.2 Liposomal Doxorubicin Regional Market Trend
9.2.1 North America Liposomal Doxorubicin Forecast 2019-2025
9.2.2 Europe Liposomal Doxorubicin Forecast 2019-2025
9.2.3 China Liposomal Doxorubicin Forecast 2019-2025
9.2.4 Japan Liposomal Doxorubicin Forecast 2019-2025
9.2.5 Southeast Asia Liposomal Doxorubicin Forecast 2019-2025
9.2.6 India Liposomal Doxorubicin Forecast 2019-2025
9.3 Liposomal Doxorubicin Market Trend (Product Type)
9.4 Liposomal Doxorubicin Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Liposomal Doxorubicin Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Executive Summary
1 Industry Overview of Liposomal Doxorubicin
1.1 Definition of Liposomal Doxorubicin
1.2 Liposomal Doxorubicin Segment by Type
1.2.1 Global Liposomal Doxorubicin Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Intravenous Infusion
1.2.3 Injection
1.3 Liposomal Doxorubicin Segment by Applications
1.3.1 Global Liposomal Doxorubicin Consumption Comparison by Applications (2014-2025)
1.3.2 Academic
1.3.3 Hospitals
1.3.4 Other
1.4 Global Liposomal Doxorubicin Overall Market
1.4.1 Global Liposomal Doxorubicin Revenue (2014-2025)
1.4.2 Global Liposomal Doxorubicin Production (2014-2025)
1.4.3 North America Liposomal Doxorubicin Status and Prospect (2014-2025)
1.4.4 Europe Liposomal Doxorubicin Status and Prospect (2014-2025)
1.4.5 China Liposomal Doxorubicin Status and Prospect (2014-2025)
1.4.6 Japan Liposomal Doxorubicin Status and Prospect (2014-2025)
1.4.7 Southeast Asia Liposomal Doxorubicin Status and Prospect (2014-2025)
1.4.8 India Liposomal Doxorubicin Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Liposomal Doxorubicin
2.3 Manufacturing Process Analysis of Liposomal Doxorubicin
2.4 Industry Chain Structure of Liposomal Doxorubicin
3 Development and Manufacturing Plants Analysis of Liposomal Doxorubicin
3.1 Capacity and Commercial Production Date
3.2 Global Liposomal Doxorubicin Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Liposomal Doxorubicin
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Liposomal Doxorubicin Production and Capacity Analysis
4.2 Liposomal Doxorubicin Revenue Analysis
4.3 Liposomal Doxorubicin Price Analysis
4.4 Market Concentration Degree
5 Liposomal Doxorubicin Regional Market Analysis
5.1 Liposomal Doxorubicin Production by Regions
5.1.1 Global Liposomal Doxorubicin Production by Regions
5.1.2 Global Liposomal Doxorubicin Revenue by Regions
5.2 Liposomal Doxorubicin Consumption by Regions
5.3 North America Liposomal Doxorubicin Market Analysis
5.3.1 North America Liposomal Doxorubicin Production
5.3.2 North America Liposomal Doxorubicin Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Liposomal Doxorubicin Import and Export
5.4 Europe Liposomal Doxorubicin Market Analysis
5.4.1 Europe Liposomal Doxorubicin Production
5.4.2 Europe Liposomal Doxorubicin Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Liposomal Doxorubicin Import and Export
5.5 China Liposomal Doxorubicin Market Analysis
5.5.1 China Liposomal Doxorubicin Production
5.5.2 China Liposomal Doxorubicin Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Liposomal Doxorubicin Import and Export
5.6 Japan Liposomal Doxorubicin Market Analysis
5.6.1 Japan Liposomal Doxorubicin Production
5.6.2 Japan Liposomal Doxorubicin Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Liposomal Doxorubicin Import and Export
5.7 Southeast Asia Liposomal Doxorubicin Market Analysis
5.7.1 Southeast Asia Liposomal Doxorubicin Production
5.7.2 Southeast Asia Liposomal Doxorubicin Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Liposomal Doxorubicin Import and Export
5.8 India Liposomal Doxorubicin Market Analysis
5.8.1 India Liposomal Doxorubicin Production
5.8.2 India Liposomal Doxorubicin Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Liposomal Doxorubicin Import and Export
6 Liposomal Doxorubicin Segment Market Analysis (by Type)
6.1 Global Liposomal Doxorubicin Production by Type
6.2 Global Liposomal Doxorubicin Revenue by Type
6.3 Liposomal Doxorubicin Price by Type
7 Liposomal Doxorubicin Segment Market Analysis (by Application)
7.1 Global Liposomal Doxorubicin Consumption by Application
7.2 Global Liposomal Doxorubicin Consumption Market Share by Application (2014-2019)
8 Liposomal Doxorubicin Major Manufacturers Analysis
8.1 Johnson & Johnson
8.1.1 Johnson & Johnson Liposomal Doxorubicin Production Sites and Area Served
8.1.2 Johnson & Johnson Product Introduction, Application and Specification
8.1.3 Johnson & Johnson Liposomal Doxorubicin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer
8.2.1 Pfizer Liposomal Doxorubicin Production Sites and Area Served
8.2.2 Pfizer Product Introduction, Application and Specification
8.2.3 Pfizer Liposomal Doxorubicin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Sun Pharmaceutical
8.3.1 Sun Pharmaceutical Liposomal Doxorubicin Production Sites and Area Served
8.3.2 Sun Pharmaceutical Product Introduction, Application and Specification
8.3.3 Sun Pharmaceutical Liposomal Doxorubicin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Cadila Pharmaceuticals
8.4.1 Cadila Pharmaceuticals Liposomal Doxorubicin Production Sites and Area Served
8.4.2 Cadila Pharmaceuticals Product Introduction, Application and Specification
8.4.3 Cadila Pharmaceuticals Liposomal Doxorubicin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
9 Development Trend of Analysis of Liposomal Doxorubicin Market
9.1 Global Liposomal Doxorubicin Market Trend Analysis
9.1.1 Global Liposomal Doxorubicin Market Size (Volume and Value) Forecast 2019-2025
9.2 Liposomal Doxorubicin Regional Market Trend
9.2.1 North America Liposomal Doxorubicin Forecast 2019-2025
9.2.2 Europe Liposomal Doxorubicin Forecast 2019-2025
9.2.3 China Liposomal Doxorubicin Forecast 2019-2025
9.2.4 Japan Liposomal Doxorubicin Forecast 2019-2025
9.2.5 Southeast Asia Liposomal Doxorubicin Forecast 2019-2025
9.2.6 India Liposomal Doxorubicin Forecast 2019-2025
9.3 Liposomal Doxorubicin Market Trend (Product Type)
9.4 Liposomal Doxorubicin Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Liposomal Doxorubicin Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
